Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Short Interest Update

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) was the recipient of a significant growth in short interest in January. As of January 30th, there was short interest totaling 1,192,172 shares, a growth of 21.2% from the January 15th total of 983,500 shares. Based on an average daily trading volume, of 60 shares, the days-to-cover ratio is presently 19,869.5 days. Based on an average daily trading volume, of 60 shares, the days-to-cover ratio is presently 19,869.5 days.

Shanghai Fosun Pharmaceutical (Group) Stock Performance

Shares of SFOSF stock opened at $2.61 on Wednesday. The company’s fifty day simple moving average is $2.82 and its two-hundred day simple moving average is $2.97. Shanghai Fosun Pharmaceutical has a 52 week low of $1.62 and a 52 week high of $3.50.

About Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China‐based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small‐molecule drugs, bio‐pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.

The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.